CLPT amendment: 10b5-1 sale of 26,463 shares

CLPT submitted an amendment to a Form 144/A reporting resale activity in Common stock, including a 10b5-1 sale of 26,463 shares on 10/10/2025 for $714,032.60.

Accepted by SEC EDGAR 02/20/2026 - 04:48 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

CLPT submitted an amendment to a Form 144/A reporting resale activity in Common stock, including a 10b5-1 sale of 26,463 shares on 10/10/2025 for $714,032.60. The amendment lists prior and planned issuer awards under employee plans with dated grant entries.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What 10b5-1 sale does CLPT report in this 144/A?

The amendment reports a 10b5-1 sale of 26,463 shares on 10/10/2025 realized for $714,032.60. The sale is attributed to the Joseph M. Burnett Trust dated 10/20/2022 as listed in the filing.

Does the CLPT filing show any issuer awards or plans?

Yes. The amendment lists issuer-side grants under employee plans, including an Employee Stock Purchase Plan entry and multiple Restricted Stock Awards with dated grant entries on 12/29/2023, 06/10/2025, and 06/10/2024 and specified share counts.

Which security class and exchange are referenced in the CLPT amendment?

The filing references Common stock and indicates NASDAQ as the exchange. The amendment includes multiple dated entries tied to Common shares and plan-related issuances shown in the submission.

Who is the selling party named for the reported sale?

The sale is reported for the Joseph M. Burnett Trust dated 10/20/2022, with an address listed in Solana Beach, CA. The trust is identified as the party associated with the 10b5-1 sale of 26,463 shares on 10/10/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK	0001721010
Filer CCC	XXXXXXXX
Previous Accession Number Of The Filing	0001950047-26-000303
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer	ClearPoint Neuro, Inc.
SEC File Number	001-34822
Address of Issuer	120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CALIFORNIA 92075
Phone	9499006833
Name of Person for Whose Account the Securities are To Be Sold	BURNETT JOSEPH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	306200.00	28423308	01/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/29/2023	Employee Stock Purchase Plan	Issuer			6496	12/29/2023	Cash
Common	06/10/2025	Restricted Stock Awards	Issuer			12570	06/10/2025	N/A
Common	06/10/2024	Restricted Stock Awards	Issuer			934	06/10/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for Joseph M. Burnett Trust dated 10/20/2022 120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CA 92075	Common	10/10/2025	26463	714032.60

144/A: Remarks and Signature

Remarks	This amendment to the Form 144 filed on 1/9/2026 is being made to correct the nature of acquisition transaction for the shares sold.
Date of Notice	02/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joseph Michael Burnett
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)